Showing results (471-480 of 498) with videos related to
Sort By:
Pageof 50
Scientific Reports|June 15, 2021
Sensitive detection and quantification of SARS-CoV-2 in salivaMustafa Fatih Abasiyanik, Blake Flood, Jing Lin, et al.World Neurosurgery|June 10, 2023
The World Neurosurgery Global Champions Program: First-Year Experience of a Model Initiative for Reducing Disparities in Global Neurosurgical LiteratureNathan A Shlobin, Simon Savage, Alexander Savage, et al.Journal of Virology|October 27, 2021
Distinct Roles of Type I and Type III Interferons during a Native Murine β Coronavirus Lung InfectionLokesh Sharma, Xiaohua Peng, Hua Qing, et al.Journal of the American College of Cardiology|January 1, 2016
Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST IITed Feldman, Saibal Kar, Sammy Elmariah, et al.JACC. Heart Failure|February 5, 2025
Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline CharacteristicsPablo Garcia-Pavia, Ozlem Bilen, Melissa Burroughs, et al.Journal of the American College of Surgeons|September 13, 2023
Development and Validation of a Novel Hollow Viscus Injury Prediction Score for Abdominal Seatbelt Sign: A Pacific Coast Surgical Association Multicenter StudyJeffrey Santos, Patrick T Delaplain, Erika Tay-Lasso, et al.Nature|September 17, 2015
Epicardial FSTL1 reconstitution regenerates the adult mammalian heartKe Wei, Vahid Serpooshan, Cecilia Hurtado, et al.Archives of Internal Medicine|March 11, 2009
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort StudyDavid R Murdoch, G Ralph Corey, Bruno Hoen, et al.Journal of the American College of Cardiology|May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.Journal of the American College of Cardiology|October 30, 2024
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCMAhmad Masri, Lubna Choudhury, Roberto Barriales-Villa, et al.Pageof 50